Catalyst
Slingshot members are tracking this event:
VLP Therapeutics Announces Issuance of U.S. Composition of Matter Patent for i-α Virus Like Particle Platform Technology; Intellectual Property Estate Strengthens Malaria, Dengue and Zika Virus Disease Program
- Source Link:
- http://vlptherapeutics.com/press-release-en/12409/
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
VLP |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 08, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Matter Patent, I-α Virus, Particle Platform Technology, Intellectual Property, Malaria, Dengue, Zika, I-αvlp, Chikungunya Virus, Alphavirus Virus-like Particle